2National institutes of health(NIH).National Heart,Lung and Blood Institute (NHLBI)/World Health Organization (WHO).Global strategy for asthma management and prevention.Global initiative for asthma.No.02-3659.NIH Publication,2002.1-172.
3Holgate ST.Therapeutic options for persistent asthma.JAMA,2001,285:2637-2639.
5Nelson HS,Chapman KR,Pyke SD,et al.Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers.J Allergy Clin Immunol,2003,112:29-36.
6Pauwels RA,Lofdahl CG,Postma DS,et al.Effect of inhaled formoterol and budesonide on exacerbations of asthma.Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.N Engl J Med,1997,337:1405-1411.
7O'Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial.Am J Respir Crit Care Med,2001,164(8Pt 1):1392-1397.
8Tal A,Simon G,Vermeulen JH,et al.Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.Pediatr Pulmonol,2002,34:342-350.
9Scicchitano R,Aalbers R,Ukena D,et al.Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.Curr Med Res Opin,2004,20:1403-1418.
2WHO/NHLIB Workshop Report. Global strategy for asthma management and prevention. NIH publication No. 02-3659,2002. 2,127-128.
3Johnson M. Pharmacology of long-acting beta-agonists. Ann Allergy Asthma Immunol,1995,75:177-179.
4O′Connor BJ,Fuller RW,Barnes PJ. Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate-than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med,1994,150:381-387.
5Johnson M. Effects of beta 2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol,2002,110(6 Suppl):S282-S290.
6Barnes PJ. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol,1996,97(1 Pt 2):159-168.
7Mak JC,Nishikawa M,Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol,1995,268(1 Pt 1):L41-L46.
8Baraniuk JN,Ali M,Brody D,et al. Glucocorticoids induce beta 2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med,1997,155:704-710.
9Eickelberg O,Roth M,Lorx R,et al. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem,1999,274:1005-1010.
10Johnson M. Combination therapy for asthma:complementary effects of long acting beta2 agonists and corticosteroids. Current Allergy & Clin Immunol,2002,15:16-22.
